Phase 1 study of MEDI0562, a humanized OX40 agonist monoclonal antibody (mAb), in adult patients (pts) with advanced solid tumors

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 27; p. vi361
Main Authors	Glisson, B.S., Leidner, R., Ferris, R.L., Powderly, J., Rizvi, N., Norton, J.D., Burton, J., Lanasa, M.C., Patel, S.P.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.10.2016
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdw378.07